You are on page 1of 4

[Downloadedfreefromhttp://www.meajo.orgonSunday,August31,2014,IP:190.12.28.

242]||ClickheretodownloadfreeAndroidapplicationforthisjournal

Case Report
Management of Paradoxical Response in Pediatric
Tubercular Meningitis with Methylprednisolone
Nitin Nema, Abha Verma, Kuldeep Singh1, Virendra Mehar1

Access this article online

ABSTRACT
Paradoxical response to antitubercular drugs remains a diagnostic dilemma. In India where
tuberculosis is quite prevalent, paradoxical response to antitubercular treatment(ATT) is
either misdiagnosed or underdiagnosed. We report two cases of optochiasmatic arachnoiditis
due to paradoxical response in children suffering from tuberculous meningitis. Visual acuity
was recorded as no light perception in all eyes of both patients while they were taking 4drug
ATT(isoniazid, rifampicin, pyrazinamide and ethambutol). However their systemic conditions
did not worsen. They were treated with intravenous methylprednisolone for five days followed
by systemic corticosteroids on a tapering dose for four weeks along with ATT. This case report
highlights the importance of early recognition of this sightthreatening complication and
timely, effective treatment to prevent permanent blindness.

Website:
www.meajo.org
DOI:
10.4103/0974-9233.129775
Quick Response Code:

Key words: AntiTubercular Treatment, Intravenous Methylprednisolone, Optochiasmatic


Arachnoiditis, Paradoxical Response, Tubercular Meningitis

INTRODUCTION

he incidence of tuberculosis is quite high in India. 1


Tuberculous meningitis(TBM) is the most devastating form
of extrapulmonary tuberculosis in children,2,3 especially males.4,5
Therefore, TBM is an important cause of optochiasmatic
arachnoiditis(OCA) in the Indian subcontinent.6
OCA is an inflammation around the optic chiasm and optic
nerves. This inflammatory involvement of anterior visual
pathway results in marked exudation in the leptomeninges6
seen on magnetic resonance imaging(MRI) as basal exudates,
which are most prominent around the optic chiasm.7,8 It
may occur during the course of neurotuberculosis or as a
paradoxical response to antitubercular treatment(ATT).6,9
OCA leads to profound visual impairment and, without timely
diagnosis and effective treatment, it may cause irreversible
blindness.6,10
Reports of OCA are rare in the literature particularly in pediatric
patients. We report two cases of OCA who developed blindness

due to a paradoxical response to ATT and the successful


management of these cases.

CASE REPORTS
Case 1

A sixyearold male, who was fully immunized and his


vaccinations were current, was treated for stage II TBM for one
month, with good response, developed profound diminution
of vision. He was on oral 4drug ATT, that comprised
of isoniazid (5mg/kg/day), rifampicin(10mg/kg/day),
pyrazinamide (25mg/kg/day) and ethambutol(15mg/kg/day),
and systemic steroids(1mg/kg/day) on a tapering dose.
The visual acuity was no light perception in both eyes. The
anterior segment examination was unremarkable except
for semidilated pupils, which were not reactive to light.
The fundus examination showed slight disc hyperemia with
welldefined margins bilaterally. Brain magnetic resonance
imaging(MRI) showed extensive enhancing basal exudates
along with dilatation of lateral and third ventricles and
obstruction at the aqueductal level[Figure1]. Adiagnosis of

Departments of Ophthalmology, 1Pediatrics, Sri Aurobindo Institute of Medical Sciences, Indore, Madhya Pradesh, India
Corresponding Author: Dr.Nitin Nema, Department of Ophthalmology, SAIMS, 55 Shri Nagar Main, Indore452 018, Madhya Pradesh, India.
Email:nemanitin@yahoo.com

Middle East African Journal of Ophthalmology, Volume 21, Number 2, April - June 2014

189

[Downloadedfreefromhttp://www.meajo.orgonSunday,August31,2014,IP:190.12.28.242]||ClickheretodownloadfreeAndroidapplicationforthisjournal

Nema, etal.: Management of Paradoxical Response with Methylprednisolone

paradoxical tuberculous OCA was made on the basis of MRI


findings, cerebrospinal fluid(CSF) analysis (cells 910/cu mm,
protein 230mg/dL, glucose 30mg/dL, Pandy test positive),
and clinical findings. Under cover of ATT, intravenous
methylprednisolone(IVMP), 30mg/kg body weight/day, was
administered. After three doses the visual acuity increased
to light perception in both eyes. IVMP was continued for
two more days and then the medication was changed to oral
prednisolone tablets (2mg/kg body weight/day in single
dose) on a tapering schedule for a month. The vision slowly
improved over a period of 12weeks. Seven months after
the visual loss, brain MRI showed decreased inflammation
of the meningeal sheaths around the optic nerves and mild
hydrocephalus[Figure2]. ATT was stopped after 12months.
At the 18months followup visit, the best corrected vision
was 6/18 in right eye and 6/12 in the left. The pupils in both
eyes were approximately 4mm in diameter round and briskly
reactive to torch light. Fundus examination showed optic disc
pallor bilaterally[Figure3].
Case 2

A fouryearold male child, fully immunized and his vaccinations


were current, had stage I TBM with hydrocephalus, was
on oral ATT for three weeks. He underwent surgery for
ventriculoperitoneal shunt(VP shunt) under general
anesthesia after his systemic condition stabilized. Preoperative

Figure1: Contrastenhanced MRI brain showing enhancing basal exudates in the


perichiasmal region(arrow) with moderate dilatation of lateral and third ventricles
and aqueductal obstruction

Figure3: aand b. Diffuse bilateral optic disc pallor

190

ophthalmoscopic examination showed a normal fundus.


Sixdays postoperatively, the child was referred back to us by
the pediatric surgeon with complaints of bilateral loss of vision.
The child was on 4drug ATT(isoniazid 5mg/kg/day, rifampicin
10mg/kg/day, pyrazinamide 25mg/kg/day and ethambutol
15mg/kg/day) but not on systemic steroids. The visual acuity
at this visit was no fixation or following of light. There was no
light perception in both eyes with absence of pupillary reaction
to light. Fundus examination by indirect ophthalmoscope
and 78 D slitlamp ophthalmoscopy showed normal fundi
bilaterally. Brain MRI showed enhancing lesions at the level
of optic chiasm involving both the optic nerves. Adiagnosis
of paradoxical OCA was made on the basis of the clinical
picture, CSF analysis (cells 120/cu mm, 90% lymphocytes,
protein 20mg/dL) and neuroimaging findings. The child was
started on 30mg/kg body weight IVMP for five days and then
placed on systemic prednisolone (2mg/kg body weight/day)
on tapering dose along with systemic ATT. Two weeks after
starting systemic corticosteroids, the child started to perceive
light on vision testing. ATT was stopped after a year and the
best corrected visual acuity at that time was 6/18 in both eyes.
The pupils were round, semidilated with brisk reaction to light.
Fundus examination showed prominent temporal pallor of the
optic nerve head in both eyes[Figure4]. Magnetic resonance
imaging of the brain showed VP shunt insitu with no evidence
of exudate in the optochiasmatic region.

Figure2: Contrastenhanced MRI brain seven months after initiation of treatment


showing decreased exudates around the optochiasmatic region (arrow)

Figure4: Optic discs of right(a) and left(b) eyes showing pallor

Middle East African Journal of Ophthalmology, Volume 21, Number 2, April - June 2014

[Downloadedfreefromhttp://www.meajo.orgonSunday,August31,2014,IP:190.12.28.242]||ClickheretodownloadfreeAndroidapplicationforthisjournal

Nema, etal.: Management of Paradoxical Response with Methylprednisolone

DISCUSSION
Tuberculosis is a common cause of morbidity and mortality in
developing countries such as India. TBM is the most serious
form of TB in children below five years of age.2,3 There is
preponderance of the disease in male children.4,5
OCA refers to inflammatory changes with exudates in the
leptomeninges around the optic chiasm and the optic nerve.6
Tuberculosis is endemic in India, hence, OCA can occur during
the course of treatment for TBM or following withdrawal
of systemic steroids.6,9 OCA is the leading cause of visual
impairment in TBM.6,10 Early recognition of this condition and
appropriate treatment can prevent further visual loss and, at
least, salvage some functional vision.6
A reliable method of establishing the diagnosis of OCA includes
visual complaints, abnormal pupillary reactions to light, dilated
fundus examination with special attention on the examination of
optic nerve head and contrastenhanced MRI. Dense plaquelike
basal exudates especially around the optic chiasm are seen on
MRI that show enhancement and hypertrophy of the chiasm
and proximal optic nerves.11 These features may be associated
with hydrocephalus.6
Paradoxical reaction is defined as appearance of fresh symptoms,
physical and radiological signs in a patient who had shown
improvement with ATT.9 It may present while the patient is on
ATT and steroids.6 It can occur as early as 2weeks and as late
as 18months after the initiation of ATT.12 Paradoxical response
must be differentiated from drugresistant tuberculosis where
there is a worsening of the patient symptoms. In the absence of
specific CSF findings and negative culture report, the diagnosis
of paradoxical deterioration depends mainly on close clinical
monitoring.12
The paradoxical response to ATT is an exaggerated host-organism
interaction resulting in massive inflammation.12,13 Effective
treatment with ATT leads to revival of the hosts immune system.
Additionally, the death of M.tuberculosis causes activation and
accumulation of lymphocytes and macrophages at the site of
bacterial deposition or toxin production.12 This is predominantly
seen in the basal region of the brain implicating the optic chiasm
and optic nerves.
The management of OCA remains a challenge and prognosis in
most of the cases remains poor.14 Systemic oral corticosteroids,
IVMP, 6 intrathecal hyaluronidase, 15 thalidomide 16 and
microsurgical scraping of exudates have been used to treat
OCA with variable results.
The treatment of OCA due to paradoxical reaction includes
highdose systemic corticosteroids along with continuation of

ATT. The rationale behind the use of adjuvant steroids lies in


reducing the harmful effects of inflammation as antitubercular
drugs kill the organisms.9 Treatment with corticosteroids
decreases the basal exudates and stabilizes vision, and in some
cases improves vision.6
In this case report, the two children were responding well to
ATT when they noticed profound vision loss. The first child was
receiving systemic steroid on a tapering dose while the second
child was on ATT only. Both cases were small male children with
high protein content and cell count in the CSF who developed
paradoxical OCA. They responded well to intensive highdose
intravenous methylprednisolone and systemic corticosteroids
with reasonably good final visual acuity.

CONCLUSION
Ophthalmologists and pediatricians should be aware of the
paradoxical response to ATT. One must predict OCA in children
suffering from TBM who present with severe visual loss without
systemic deterioration and with high CSF protein and pleocytosis
and perichiasmal exudates on MRI. Prompt treatment with
IVMP followed by oral steroid may salvage vision in these
children.

REFERENCES
1.

ChakrabortyAK. Epidemiology of tuberculosis: Current status


in India. Indian J Med Res 2004;120:24876.
2. MaltezouHC, SpyridisP, KafetzisDA. Extrapulmonary
tuberculosis in children. Arch Dis Child 2000;83:3426.
3. WeirMR, ThortonGF. Extrapulmonary tuberculosis.
Experience of a community hospital and review of the literature.
Am J Med 1985;79:46778.
4. UdaniPM, ParekhUC, ShahPM, NaikPA. B.C.G. test in
tuberculosis. Indian Pediatr 1971;8:14350.
5. BenkappaDG, ChandrashekharSK, ChandrashekharP,
KakkurM, Bhargava KrishnaM. Tuberculous meningitis: Review
of 50cases. Indian Pediatr 1975;12:11617.
6. AnupriyaA, SunithiM, MayaT, GoelM, AlexanderM,
AaronS, etal. Tuberculous optochiasmatic arachnoiditis.
Neurol India 2010;58:7325.
7. DasturDK, LalithaVS, UdaniPM, ParekhU. The brain and
meninges in tuberculous meningitisGross pathology in
100cases and pathogenesis. Neurol India 1970;18:86100.
8. GargRK, PaliwalV, MalhotraHS. Tuberculous optochiasmatic
arachnoiditis: Adevastating form of tuberculous meningitis.
Expert Rev Anti Infect Ther 2011;9:71929.
9. MongaPK, DhaliwalU. Paradoxical reaction in tuberculous
meningitis resulting in involvement of optic radiation. India J
Ophthalmol 2009;57:13941.
10. SinhaMK, GargRK, AnuradhaHK, AgarwalA, SinghMK,
VermaR, etal. Vision impairment in tuberculous meningitis:
Predictors and prognosis. JNeurol Sci 2010;290:2732.
11. SilvermanIE, LiuGT, BilaniukLT, VolpeNJ, GalettaSL.
Tuberculous meningitis with blindness and perichiasmal
involvement on MRI. Pediatr Neurol 1995;12:657.
12. GuptaM, BajajBK, KhwajaG. Paradoxical response in

Middle East African Journal of Ophthalmology, Volume 21, Number 2, April - June 2014

191

[Downloadedfreefromhttp://www.meajo.orgonSunday,August31,2014,IP:190.12.28.242]||ClickheretodownloadfreeAndroidapplicationforthisjournal

Nema, etal.: Management of Paradoxical Response with Methylprednisolone


patients with CNS tuberculosis. JAssoc Physicians India
2003;51:25760.
13. ZakiSA, ShenoyP. Paradoxical response to antitubercular
treatment. Indian J Pharmacol 2011;43:2123.
14. G o u r i e D e v i M . O p t o c h i a s m a t i c a r a c h n o i d i t i s a n d
neurotuberculosis. Prognostic indicators and therapeutic
strategies. Neurol India 2010;58:7145.
15. GourieDeviM, SatishP. Hyaluronidase as an adjuvant in
the treatment of cranial arachnoiditis(Hydrocephalus and
optochiasmatic arachnoiditis) complicating tuberculous

192

meningitis. Acta Neurol Scand 1980;62:36881.


16. SchoemanJF, AndronikouS, StefanDC, FreemanN, van
ToomR. Tuberculous meningitisrelated optic neuritis:
Recovery of vision with thalidomide in 4 consecutive cases.
JChild Neurol 2010;25:8228.
Cite this article as: Nema N, Verma A, Singh K, Mehar V. Management of
paradoxical response in pediatric tubercular meningitis with methylprednisolone.
Middle East Afr J Ophthalmol 2014;21:189-92.
Source of Support: Nil, Conflict of Interest: None declared.

Middle East African Journal of Ophthalmology, Volume 21, Number 2, April - June 2014

You might also like